ArticleIndian journal of dermatology

Real-World Efficacy and Safety of Oral Tofacitinib in Patients with Refractory Moderate to Severe Atopic Dermatitis: A Multicenter Retrospective Study.

Sandipan Dhar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.